TCL Archive In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished February 12, 1988
TCL Archive CPRIT Likely to Get Funding For Two Years; DePinho Announces Austerity Measures May 17, 2013
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009